https://rigosertibinhibitor.co....m/stability-side-pas
The primary endpoint is a composite of all-cause mortality, recurrent MI, intense decompensated heart failure, unstable angina pectoris, or stroke. The principal composite endpoint are going to be examined through locally reported and adjudicated endpoints supplemented by linkage into the Danish nationwide registers. Lots of secondary endpoints will likely to be examined including patient reported outcomes and cardio mortality. Information from similar continuous trials in Norway and Sweden w
Respect!
Kommentar
Delen
